Future treatments for acne vulgaris should be personalized and modulate the cutaneous microbiome, according to study results published in the Journal of the European Academy of Dermatology and ...
Earlier this week, the FDA announced that 95 skin care products on the market containing benzoyl peroxide may be at risk for something called benzene contamination, which means they contain at least ...
Please provide your email address to receive an email when new articles are posted on . 52.7% of pediatric patients treated with the triple-combination gel vs. 24% of vehicle-treated patients achieved ...
Add Yahoo as a preferred source to see more of our stories on Google. Acne is a concern for teens and adults alike, with many turning to over-the-counter or prescription remedies. However, there is ...
The selection of patients, duration of therapy, and combination with other drug categories are key factors in optimizing antibiotic use for acne vulgaris, helping to minimize their contribution to the ...
LAVAL, QC / ACCESS Newswire / August 21, 2025 / Bausch Health (BHC), Canada Inc., part of Bausch Health Companies Inc., a global, diversified pharmaceutical company, today announced that Pr CABTREO ™ ...
Acne is one of the most common skin concerns, especially among teenagers and young adults. While pimples may eventually heal, they often leave behind visible marks on the skin. Many people assume ...
When I first notice a pimple on my face, my instinct is to pick and peel at my skin until the pimple pops or crusts over (a habit that often leaves some acne scars behind). Over the years, I’ve ...
Wellbeing Magazine on MSN
From acne to anti-aging: Dermatology services that cover it all
Your skin has a lot to say. And honestly? It never really shuts up. One decade you're fighting breakouts, the next you're ...
Please provide your email address to receive an email when new articles are posted on . Higher cumulative doses of isotretinoin showed a decreased risk for acne relapse. These findings suggest an ...
LAVAL, QC / ACCESS Newswire / July 9, 2025 / Bausch Health, Canada Inc., part of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC), today announced that PrCABTREOTM (clindamycin phosphate, adapalene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results